Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA.

Neuropsychopharmacology. 2012 Mar;37(4):1026-35. doi: 10.1038/npp.2011.287. Epub 2011 Nov 16.

2.

Candidate gene polymorphisms predicting individual sensitivity to opioids.

Kasai S, Hayashida M, Sora I, Ikeda K.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):269-81. Epub 2007 Nov 13. Review.

PMID:
17999051
3.

An animal model of differential genetic risk for methamphetamine intake.

Phillips TJ, Shabani S.

Front Neurosci. 2015 Sep 23;9:327. doi: 10.3389/fnins.2015.00327. eCollection 2015. Review.

Supplemental Content

Support Center